160 related articles for article (PubMed ID: 12684696)
1. Increased serum levels of macrophage inflammatory protein-3alpha in hepatocellular carcinoma: relationship with clinical factors and prognostic importance during therapy.
Yamauchi K; Akbar SM; Horiike N; Michitaka K; Onji M
Int J Mol Med; 2003 May; 11(5):601-5. PubMed ID: 12684696
[TBL] [Abstract][Full Text] [Related]
2. Production of macrophage inflammatory protein-3alpha in human follicular fluid and cultured granulosa cells.
Kawano Y; Fukuda J; Nasu K; Nishida M; Narahara H; Miyakawa I
Fertil Steril; 2004 Oct; 82 Suppl 3():1206-11. PubMed ID: 15474097
[TBL] [Abstract][Full Text] [Related]
3. High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies.
Poon RT; Lau C; Pang R; Ng KK; Yuen J; Fan ST
Ann Surg Oncol; 2007 Jun; 14(6):1835-45. PubMed ID: 17406950
[TBL] [Abstract][Full Text] [Related]
4. High plasma concentrations of nitrite/nitrate in patients with hepatocellular carcinoma.
Moriyama A; Masumoto A; Nanri H; Tabaru A; Unoki H; Imoto I; Ikeda M; Otsuki M
Am J Gastroenterol; 1997 Sep; 92(9):1520-3. PubMed ID: 9317076
[TBL] [Abstract][Full Text] [Related]
5. Chemokine expression in human erythroid leukemia cell line AS-E2: macrophage inflammatory protein-3alpha/CCL20 is induced by inflammatory cytokines.
Inoue Y; Tsushima H; Ando K; Sawayama Y; Sakai M; Yamasaki R; Matsuo E; Tsutsumi C; Imaizumi Y; Iwanaga M; Imanishi D; Taguchi J; Miyazaki Y; Tomonaga M
Exp Hematol; 2006 Jan; 34(1):19-26. PubMed ID: 16413387
[TBL] [Abstract][Full Text] [Related]
6. Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma.
Hayasaka A; Suzuki N; Fujimoto N; Iwama S; Fukuyama E; Kanda Y; Saisho H
Hepatology; 1996 Nov; 24(5):1058-62. PubMed ID: 8903375
[TBL] [Abstract][Full Text] [Related]
7. Human interleukin 6 gene is activated by hepatitis B virus-X protein in human hepatoma cells.
Lee Y; Park US; Choi I; Yoon SK; Park YM; Lee YI
Clin Cancer Res; 1998 Jul; 4(7):1711-7. PubMed ID: 9676846
[TBL] [Abstract][Full Text] [Related]
8. Chemokine receptor CCR6 as a prognostic factor after hepatic resection for hepatocellular carcinoma.
Uchida H; Iwashita Y; Sasaki A; Shibata K; Matsumoto T; Ohta M; Kitano S
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):161-8. PubMed ID: 16706828
[TBL] [Abstract][Full Text] [Related]
9. Increased serum levels of macrophage inflammatory protein-3alpha in chronic viral hepatitis: prognostic importance of macrophage inflammatory protein-3alpha during interferon therapy in chronic hepatitis C.
Yamauchi K; Akbar SM; Horiike N; Michitaka K; Onji M
J Viral Hepat; 2002 May; 9(3):213-20. PubMed ID: 12010510
[TBL] [Abstract][Full Text] [Related]
10. Macrophage inflammatory protein-3alpha is a novel serum marker for nasopharyngeal carcinoma detection and prediction of treatment outcomes.
Chang KP; Hao SP; Chang JH; Wu CC; Tsang NM; Lee YS; Hsu CL; Ueng SH; Liu SC; Liu YL; Wei PC; Liang Y; Chang YS; Yu JS
Clin Cancer Res; 2008 Nov; 14(21):6979-87. PubMed ID: 18980993
[TBL] [Abstract][Full Text] [Related]
11. STRL22 is a receptor for the CC chemokine MIP-3alpha.
Liao F; Alderson R; Su J; Ullrich SJ; Kreider BL; Farber JM
Biochem Biophys Res Commun; 1997 Jul; 236(1):212-7. PubMed ID: 9223454
[TBL] [Abstract][Full Text] [Related]
12. Odontoblast marker gene expression is enhanced by a CC-chemokine family protein MIP-3alpha in human mesenchymal stem cells.
Iejima D; Sumita Y; Kagami H; Ando Y; Ueda M
Arch Oral Biol; 2007 Oct; 52(10):924-31. PubMed ID: 17532291
[TBL] [Abstract][Full Text] [Related]
13. Enhanced expression and clinical significance of CC-chemokine MIP-3 alpha in hepatocellular carcinoma.
Rubie C; Frick VO; Wagner M; Rau B; Weber C; Kruse B; Kempf K; Tilton B; König J; Schilling M
Scand J Immunol; 2006 Jun; 63(6):468-77. PubMed ID: 16764701
[TBL] [Abstract][Full Text] [Related]
14. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339
[TBL] [Abstract][Full Text] [Related]
15. Quantitation of alpha-fetoprotein messenger RNA for early detection of recurrent hepatocellular carcinoma: a prospective pilot study.
Schmilovitz-Weiss H; Stemmer SM; Liberzon E; Avigad S; Sulkes J; Belinki A; Kazatsker A; Ben-Ari Z
Cancer Detect Prev; 2006; 30(2):204-9. PubMed ID: 16638626
[TBL] [Abstract][Full Text] [Related]
16. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.
Harrison LE; Koneru B; Baramipour P; Fisher A; Barone A; Wilson D; Dela Torre A; Cho KC; Contractor D; Korogodsky M
J Am Coll Surg; 2003 Nov; 197(5):759-64. PubMed ID: 14585410
[TBL] [Abstract][Full Text] [Related]
17. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
18. Implications of serum basic fibroblast growth factor levels in chronic liver diseases and hepatocellular carcinoma.
Hsu PI; Chow NH; Lai KH; Yang HB; Chan SH; Lin XZ; Cheng JS; Huang JS; Ger LP; Huang SM; Yen MY; Yang YF
Anticancer Res; 1997; 17(4A):2803-9. PubMed ID: 9252719
[TBL] [Abstract][Full Text] [Related]
19. Common transcriptional signature of tumor-infiltrating mononuclear inflammatory cells and peripheral blood mononuclear cells in hepatocellular carcinoma patients.
Sakai Y; Honda M; Fujinaga H; Tatsumi I; Mizukoshi E; Nakamoto Y; Kaneko S
Cancer Res; 2008 Dec; 68(24):10267-79. PubMed ID: 19074895
[TBL] [Abstract][Full Text] [Related]
20. Chromogranin A levels in chronic liver disease and hepatocellular carcinoma.
Massironi S; Fraquelli M; Paggi S; Sangiovanni A; Conte D; Sciola V; Ciafardini C; Colombo M; Peracchi M
Dig Liver Dis; 2009 Jan; 41(1):31-5. PubMed ID: 18762462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
